Medications in pregnancy and lactation

Obstetrics and Gynecology

Volumn 114, Issue 1, 2009, Pages 166-167

  Lavigne, Sharon Voyer ^a,b   Moretti, Myla ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; CLONAZEPAM; DIAZEPAM; LAMOTRIGINE; PAROXETINE; PHENYTOIN; SERTRALINE;

ACCURACY; CARDIAC DEFECT; CLEFT FACE; CLEFT LIP; DRUG SAFETY; DRUG USE; EVIDENCE BASED MEDICINE; FETAL HYDANTOIN SYNDROME; FOOD AND DRUG ADMINISTRATION; HUMAN; INTERNET; LACTATION; LETTER; MEDICAL INFORMATION; MEDICAL INFORMATION SYSTEM; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; CONGENITAL MALFORMATION; FEMALE; NOTE;

ABNORMALITIES, DRUG-INDUCED; FEMALE; HUMANS; PREGNANCY;

EID: 67651052774     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181ac7bdd     Document Type: Letter

References (9)

1. Buhimschi CS, Weiner CP. Medications in pregnancy and lactation: part 1. Teratology. Obstet Gynecol 2009;113:166-88.
2. Einarson A, Pistelli A, DeSantis M, Malm H, Paulus WD, Panchaud A, et al Evaluation of the risk of congenital cardiovascular defects associated with the use of paroxetine during pregnancy [published errata appear in Am J Psychiatry 2008;165:777 and Am J Psychiatry 2008;165:1208]. Am J Psychiatry 2008;165:749-52.
3. Speidel BD, Meadow SR. Maternal epilepsy and abnormalities of the fetus and newborn. Lancet 1972;2:839-43.
4. Fedrick J. Epilepsy and pregnancy: A report from the Oxford Record Linkage Study. Br MedJ 1973;2:442-8.
5. Monson RR, Rosenberg L, Hartz SC, Shapiro S, Heinonen OP, Slone D. Diphenylhydantoin and selected congenital malformations. N Engl J Med 1973;289:1049-52.
6. Hill RM, Verniaud WM, Horning MG, McCulley LB, Morgan NF. Infants exposed in utero to antiepileptic drugs. A prospective study. Am J Dis Child 1974;127:645-53.
7. Hanson JW, Smith DW. The fetal hydantoin syndrome. J Pediatr 1975;87:285-90.
8. Holmes LB, Baldwin EJ, Smith CR, Habecker E, Glassman L, Wong SL, et al. Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology 2008;70:2152-8.
9. Dolk H, Jentink J, Loane M, Morris J, de Jong-van den Berg LT. Does lamotrigine use in pregnancy increase orofa- cial cleft risk relative to other malformations? Neurology 2008;71:714-22.